Evidence map›Paper›PMID 36986714›Full record

ArticlePharmaceutics2023

Pharmacokinetics of Orally Applied Cannabinoids and Medical Marijuana Extracts in Mouse Nervous Tissue and Plasma: Relevance for Pain Treatment.

Cristiana Dumbraveanu, Katharina Strommer, Meinolf Wonnemann, Jeiny Luna Choconta, Astrid Neumann, Michaela Kress, Theodora Kalpachidou, Kai K Kummer

Open access · goldAbstract read
In one paragraph

Article in Pharmaceutics, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
4.8field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 20 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. ΔDrug and alcohol dependence reports · 2023
    Article
  9. Article
  10. Article
  11. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Cristiana DumbraveanuInstitute of Physiology, Medical University of Innsbruck, 6020 Innsbruck, Austria.
Katharina StrommerBionorica Research GmbH, 6020 Innsbruck, Austria.
Meinolf WonnemannIndependent Researcher, 92318 Neumarkt, Germany.
Jeiny Luna ChocontaInstitute of Physiology, Medical University of Innsbruck, 6020 Innsbruck, Austria.
Astrid NeumannBionorica Research GmbH, 6020 Innsbruck, Austria.
Michaela KressInstitute of Physiology, Medical University of Innsbruck, 6020 Innsbruck, Austria.ORCID 0000-0002-8921-7470
Theodora KalpachidouInstitute of Physiology, Medical University of Innsbruck, 6020 Innsbruck, Austria.ORCID 0000-0002-7924-7772
Kai K KummerInstitute of Physiology, Medical University of Innsbruck, 6020 Innsbruck, Austria.ORCID 0000-0002-5854-6503
Innsbruck Medical University · ATBionorica (Austria) · AT

Funding

Austrian Science Fund FWF I 5087Austrian Science Fund FWF I 5364
6 · The paper itself

Abstract

Cannabis sativa plants contain a multitude of bioactive substances, which show broad variability between different plant strains. Of the more than a hundred naturally occurring phytocannabinoids, Δ9-Tetrahydrocannabinol (Δ9-THC) and cannabidiol (CBD) have been the most extensively studied, but whether and how the lesser investigated compounds in plant extracts affect bioavailability or biological effects of Δ9-THC or CBD is not known. We therefore performed a first pilot study to assess THC concentrations in plasma, spinal cord and brain after oral administration of THC compared to medical marijuana extracts rich in THC or depleted of THC. Δ9-THC levels were higher in mice receiving the THC-rich extract. Surprisingly, only orally applied CBD but not THC alleviated mechanical hypersensitivity in the mouse spared nerve injury model, favoring CBD as an analgesic compound for which fewer unwanted psychoactive effects are to be expected.

Indexed as

bioavailabilitycannabidiolCBDmedical marijuananeuropathic painspared nerve injurytetrahydrocannabinolTHC

Identifiers

PMID36986714
PMCPMC10057980
OpenAlexW4323318753

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.